kentucky semaglutide vomiting lawyer legal team glp-1 nausea in kentucky nausea law office Infectious Diseases kentucky semaglutide vomiting The – glp-1 intestinal paralysis law office

You may be eligible if your BMI is 30 or above, or if it is 27 or above and you have one or more related health conditions

If pregnancy prevention is important, ensuring robust contraception throughout your weight loss journey is crucial

Regulators have raised concerns about unapproved GLP-1 products, including dosing errors, quality concerns, and products marketed with misleading labels

For example, the STEP 1 trial of once-weekly semaglutide (2.4 mg) in people without diabetes achieved a ~15% average body weight reduction over 68 weeks (source), with a mean baseline BMI of ~38 (source)

SURMOUNT-5 head-to-head data The SURMOUNT-5 trial, published in the New England Journal of Medicine, was the first large-scale head-to-head comparison of tirzepatide and semaglutide

Recognizing when burning requires medical attention versus normal post-injection discomfort is essential for safe semaglutide use